1. Introduction {#sec1}
===============

Myocardial infarction (MI) was a major cause of death and disability throughout the world. After acute MI, the loss of cardiomyocyte triggers a host of molecular and cellular remodeling that initiates and subsequently modulates reparative responses including inflammation, hypertrophy, fibrosis, and the formation of a discrete collagen scar. Methods to inhibit cardiomyocyte death and increase cardiomyocyte survival can attenuate adverse remodeling and eventually improving cardiac function post-MI \[[@B1]\]. In the process of MI, the incomplete or complete occlusion of coronary arteries induced a potentially lethal shortage in the supply of oxygen and nutrients to cardiomyocytes \[[@B2]\]. Subsequently, efficient autophagic responses allow cardiomyocytes to cope with nutritional stress and maintain intracellular homeostasis, and may have considerable beneficial effects following ischemic insults \[[@B3]\]. Many studies indicated that autophagy mediates robust cardioprotective effects (such as anti-inflammation, promotion of adaptation to stress, and support for cellular viability) in MI \[[@B4], [@B5]\]. Nevertheless, a growing number of evidences suggested that excessive or dysregulated autophagy contributed to the development of many cardiovascular disorders, especially MI \[[@B6], [@B7]\]. Therefore, it is of critical importance to explore the autophagy mechanisms underlying MI and to develop novel therapeutic strategies that can effectively regulate this process.

The inhibitor of nuclear factor-*κ*B (I*κ*B) kinases *ε* (IKK*ε*) was a key regulator of many biological events \[[@B8]\]. Evidence suggests that IKK*ε* was required for the induction of the metabolic response of autophagy, which was not only typically associated with cell survival but also can cause cell death \[[@B9]\]. Recent studies have shown that IKK*ε* can regulate the formation of autophagic vacuoles by regulating the phosphorylation level of the autophagy-associated receptor ALL0-1 \[[@B10]\], and IKK*ε* also played an important regulatory role in the development of cardiovascular disease \[[@B11]\]. Until now, it remaines unclear whether IKK*ε* plays a role in the processes that occur after MI. Hence, the investigation of the pathophysiological contribution of cardiac IKK*ε* expression to MI would provide valuable understanding on cardiac remodeling.

In the present study, the role and mechanism of IKK*ε* in cardiomyocyte autophagy and cardiac function after MI were studied. We found that IKK*ε* was a critical protective mediator in the process of cardiac remodeling after MI. Loss of IKK*ε* induces excessive cardiomyocyte autophagy and reduced the expression of p-Akt and p-mTOR. And the levels of p-Akt and p-mTOR can restore in IKK*ε* rescued H9c2 cells under starvation injury. Our results indicated that IKK*ε* protects cardiomyocyte survival by reduced autophagy following MI via regulation of the Akt/mTOR signaling pathway.

2. Materials and Methods {#sec2}
========================

2.1. Animal Experiments {#sec2.1}
-----------------------

All animal procedures were performed in compliance with the Institute of Laboratory Animal Research *Guide for the Care and Use of Laboratory Animals* of the National Institutes of Health and approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (Ethics Committee of Nanjing First Hospital). The IKK*ε* KO mice (B6.Cg-Ikbketm1Tman/J) were obtained from Jackson laboratory (Bar Harbor, ME, USA) and underwent rederivation to achieve pathogen-free status in the Model Animal Research Center of Nanjing University (Nanjing, China). For animals, IKK*ε* KO mice with wild-type (WT) littermate (male; 8 to 12 weeks old; 26-30 g) were kept in a 12/12 h light/dark cycle, 25°C, with ad libitum access to food and water. MI was induced via permanent ligation of the left anterior descending (LAD) artery with a 6-0 Prolene suture for 28 days; in sham-operated animals, the same procedure was performed but without ligation. Specific details were performed as described previously \[[@B12]\].

2.2. Echocardiography and Micro-PET/CT {#sec2.2}
--------------------------------------

To evaluate the cardiac function, transthoracic echocardiography was performed using the Vevo 2100 echocardiogram (Visual Sonics, Canada) with a 10 MHz linear array ultrasound transducer. Mice were anesthetized by 1% to 2% isoflurane inhalation in a chamber. LV end-diastolic dimension (LVEDd), LV end-systolic dimension (LVESd), and LV wall thickness were measured from M-mode images of echocardiography. Ejection fraction (EF) and fractional shortening (FS) were calculated. Echocardiographic measurements were taken from more than 3 separate mice of each group, and the sonographer was blinded to the information of the experimental group. Other specific details were performed as described previously \[[@B13]\].

Micro-PET/CT scanning for detection of viable myocardium was performed as previously described \[[@B14]\]. Mice were anesthetized by 1% to 2% isoflurane inhalation in a chamber for the 18F-FDG injection (tail vein) and placed back in the anesthesia cage. After 40 minutes, mice were anesthetized with ketamine 100 mg/kg and xylazine 10 mg/kg (injection volume, 100 lL/10 g). Thereafter, the mice, with the heart centered in the tomograph, were symmetrically positioned on a warm bed with micropore tape, and a 15-minute static PET scan was performed, followed by a 7-minute CT scan.

2.3. Histological and Immunohistochemical Analysis {#sec2.3}
--------------------------------------------------

At different time points after surgery, mice were anesthetized intraperitoneally using sodium pentobarbital (100 mg/kg) and killed by swift decapitation according to the *Guide for the Care and Use of Laboratory Animals* published by the United States National Institutes of Health. The mouse hearts were fixed in 4% paraformaldehyde overnight at 4°C and then dehydrated through a graded ethanol series, cleared in xylenes, and embedded in paraffin wax. Samples were subsequently cut into 4 *μ*M thick sections and stained with HE. For immunohistochemical studies, the sections were treated with 3% hydrogen peroxide for 15 min to block endogenous peroxidase activity. Then, sections were sealed with normal goat serum and incubated at 4°C overnight with anti-IKK*ε* antibody (1 : 200 dilution, Cell Signaling Technology \#2690). The secondary antibody was horseradish peroxidase- (HRP-) conjugated goat anti-rabbit IgG (Beijing Zhongshan Biotechnology Co., Beijing, China). The signal was revealed by using a DAB Substrate Kit (Beijing Zhongshan Biotechnology Co.). Nuclei were counterstained with hematoxylin. Images were captured using an Olympus BX-URA2 camera with NIS-Elements D 3.2 software.

2.4. Transmission Electron Microscopy {#sec2.4}
-------------------------------------

Heart tissue was quickly cut into 1 mm cubes, fixed with 4% glutaraldehyde overnight at 4°C, fixed in 1% buffered osmium tetroxide, and was then dehydrated in graded ethanol. Sections (60--70 nm) were double stained with 1% uranyl acetate and lead citrate and examined under a Hitachi H-7650 transmission electron microscope (FEI, Tecnai G2 Spirit Bio TWIN, USA).

2.5. Cell Culture and Lentivirus Infection {#sec2.5}
------------------------------------------

The rat embryonic cardiac myoblast H9c2 cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and cultured in DMEM medium containing 10% fetal bovine serum (FBS, Gibco, Australia) and 1% antibiotic-antimycotic solution (100 U/mL penicillin and 100 *μ*g/mL streptomycin) at 37°C in a 5% CO~2~ incubator (Thermo, Waltham, MA, USA). For transfection, cells at 70% confluence were cultured in 6-well plates and infected with the lentiviral vector carrying anti-IKK*ε* siRNA (siRNA IKK*ε*); the target sequence used was GCGTTGATGCTTCGAGGGTTA; the control group used empty lentiviral vector (siRNA control).

In the rescue experiment, IKK*ε* was firstly knocked down *in vitro* by siRNA (siRNA IKK*ε*) and the cells were subsequently reinfected with LV-IKK*ε* to overexpress IKK*ε* (LV-IKK*ε*) 72 h later. In the control group, the cells of siRNA IKK*ε* were reinfected with negative control vectors (LV-control). The primers used for the vector of LV-IKK*ε* were 5′-GAGGATCCCCGGGTACCGGTCGCCACCATGCAGAGTACCACTAACTACCTG-3′; 5′-TCCTTGTAGTCCATACCGACTTCTGGTGTTGGTGGAACTATATG-3′. The medium was replaced with DMEM 24 h later according to the manufacturer\'s instructions. The efficiency of knockdown and reversal of IKK*ε* in H9c2 cells was verified by western blot analysis. For starvation, the medium was replaced with DMEM without FBS to establish starvation cell model. The autophagy flux was blocked by adding 400 nM bafilomycin A1 (Baf, Selleck, USA) to the supernatant to incubate 4 h.

2.6. Cell Immunofluorescence {#sec2.6}
----------------------------

For immunofluorescent staining, cultured H9c2 cells were treated with the indicated lentivirus for 24 h and then starved for 8 h. Cells were grown on coverslips. Following stimulation, cells were fixed with 4% paraformaldehyde at room temperature followed by ethanol treatment at -20°C and washed with PBS. Then, cells were treated with 0.5% Triton X-100 and blocked in 5% goat serum. Staining was performed with rabbit anti-LC-3 (1 : 200; Abcam, USA, \#ab51520), anti-IKK*ε* (1:200; Cell Signaling Technology, \#2690). and goat anti-rabbit Alexa Fluor 488 (Fisher Scientific) and Alexa Fluor 568 phalloidin (Fisher Scientific). Images were acquired with a Nikon (C2+) confocal microscope.

2.7. Western Blotting Analysis {#sec2.7}
------------------------------

For western blotting, total protein was extracted from cardiac tissue and myocyte cells using a RIPA buffer and separated by SDS-PAGE, and the protein concentration was examined with a BCA protein assay kit (KGP902; Keygen, China). The proteins were transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA, USA) and blocked with 5% nonfat milk powder for 1 h. The membranes were probed with the following primary antibodies: anti-IKK*ε* antibody (1 : 1000; Cell Signaling, \#2690); anti-LC3 antibody (1 : 2000; Abcam, USA, \#ab51520); anti-ATG-5 antibody (1 : 1000; Cell Signaling, USA, \#2630); anti-p-AKT antibody (1 : 1000; Cell Signaling, USA, \#S473); anti-AKT antibody (1 : 1000; Cell Signaling, USA, \#C67E7); anti-mTOR antibody (1 : 1000, Cell Signaling, USA, \#7C10); and anti-p-mTOR antibody (1 : 1000; Cell Signaling, USA, \#S2448). The following day, the PVDF membranes were incubated with secondary antibodies (1 : 5000; Cell Signaling) at room temperature for 1 h. Specific proteins were detected using an ECL reagent (GE Healthcare, Piscataway, NJ, USA) and captured on Hyperfilm (Amersham, GE Healthcare). The results were then analyzed using the ImageJ software for semiquantitation of the mean gray value of each blot.

2.8. Statistical Analysis {#sec2.8}
-------------------------

The data are presented as the mean ± SE. Differences among groups were assessed by analysis of variance followed by a post hoc Tukey test. Comparisons between two groups were performed using Student\'s *t*-test. All statistical analyses were performed using Prism 6.0 software (GraphPad Software, Inc., San Diego, CA, USA). *P* \< 0.05 was considered to indicate a statistically significant difference.

3. Results {#sec3}
==========

3.1. IKK*ε* Expression Was Upregulated in the Murine Infarcted Hearts {#sec3.1}
---------------------------------------------------------------------

To investigate the potential role of IKK*ε* in the pathological processes that develop after MI, we first examined whether IKK*ε* expression levels were altered in the diseased hearts. HE staining revealed myocardial derangement in the heart post-MI compared with the sham group ([Figure 1(a)](#fig1){ref-type="fig"}). Masson\'s trichrome staining showed that myocardial fibrosis was significantly increased in the MI mice ([Figure 1(a)](#fig1){ref-type="fig"}). Compared with the control group, immunohistochemistry and western blot showed a gradual increase of IKK*ε* expression in the mouse heart subjected to MI (Figures [1(a)](#fig1){ref-type="fig"}, [1(b)](#fig1){ref-type="fig"}, and [1(c)](#fig1){ref-type="fig"}). Immunofluorescence staining also revealed that IKK*ε* was colocated with troponin-marked cardiomyocytes in the ischemic myocardium ([Figure 1(d)](#fig1){ref-type="fig"}). Collectively, the alterations of IKK*ε* levels in murine infarcted hearts indicate that IKK*ε* may be involved in postinfarction cardiac dysfunction and ventricular remodeling.

3.2. IKK*ε* Improved Cardiomyocyte Survival and Protected Cardiac Function Post-MI {#sec3.2}
----------------------------------------------------------------------------------

A mouse model with WT and global knockout (KO) of IKK*ε* ([Figure 2(a)](#fig2){ref-type="fig"}) were used with the sham or MI operation. All of the mice in the sham group were alive after surgery; 22 (70.9%) mice in the wild-type (WT) group and 18 (60%) mice in the KO group were survived until 28 days after MI, respectively. Compared with the WT group, KO mice showed higher mortality ([Figure 2(b)](#fig2){ref-type="fig"}). Echocardiography showed significant decrease of ejection fraction (EF) in KO mice post-MI (Figures [2(c)](#fig2){ref-type="fig"} and [2(g)](#fig2){ref-type="fig"}). We also observed that LV end-diastolic dimension (LVEDd) and LV end-systolic dimension (LVESd) of the heart in KO mice were higher and fractional shortening percentage (FS %) was lower when compared with WT mice post-MI (Figures [2(d)](#fig2){ref-type="fig"}, [2(e)](#fig2){ref-type="fig"}, and [2(f)](#fig2){ref-type="fig"}). Additionally, viable myocardium was significantly reduced in KO mice, as compared with the control group 14 days after MI when tested by micropositron emission tomography/computed tomography (micro-PET/CT) (Figures [2(h)](#fig2){ref-type="fig"} and [2(i)](#fig2){ref-type="fig"}). Overall, these data provide evidence that the absence of IKK*ε* in the heart increases postinfarction mortality, promotes cardiac dysfunction, and reduces viable myocardium following MI.

3.3. IKK*ε* Reduced Excessive Autophagy in Cardiomyocytes after MI {#sec3.3}
------------------------------------------------------------------

Viable myocardium reduction is caused by the increase of cardiomyocyte death, and the disorder of autophagy is one of the important causes of cell death. Our research shows that autophagy peaked two weeks post-MI in the wild-type mice and the expression of IKK*ε* also reached the highest value simultaneously (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). To further verify the effect of IKK*ε in vivo*, the expression of LC3 I/II, Beclin-1, and ATG-5 was examined in IKK*ε* KO mice 2 weeks after MI. The results showed that LC3 I/II, Beclin-1, and ATG-5 were significantly upregulated in the mice of the IKK*ε* KO group after MI (Figures [3(c)](#fig3){ref-type="fig"} and [3(d)](#fig3){ref-type="fig"}). And transmission electron microscopy analysis also demonstrated the number of autophagic cardiomyocytes increased significantly in myocardial tissue of the IKK*ε* KO mice (Figures [3(e)](#fig3){ref-type="fig"} and [3(f)](#fig3){ref-type="fig"}). The cell death genes (C-caspase 3, Bax) and anti-death protein (Bcl-2) were detected in myocardial tissue two weeks after MI. The expression of C- caspase 3 and Bax was increased, while the Bcl-2 was significant reduced in IKK*ε* KO mice when compared with the WT group (Figures [3(e)](#fig3){ref-type="fig"} and [3(f)](#fig3){ref-type="fig"}). Therefore, we speculate that IKK*ε* may protect myocardial tissue by inhibiting excessive autophagy of cardiomyocytes after MI.

3.4. IKK*ε* Prevented Cardiomyocytes from Starvation-Induced Excessive Autophagy *In Vitro* {#sec3.4}
-------------------------------------------------------------------------------------------

The expression of IKK*ε* was significantly increased in primary cultured mouse cardiomyocytes after starvation (Supplementary [1](#supplementary-material-1){ref-type="supplementary-material"}). Due to the difficulties in cell passage and low efficiency in transfection, the H9c2 cells were used for subsequent study *in vitro*. Given that cardiomyocyte autophagy could be induced at the initiation of MI due to the glycogen consumption, H9c2 cells were infected with IKK*ε*-siRNA and exposed to starvation for 8 h (Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"}) to test the role of IKK*ε* in cardiomyocyte autophagy. The knockdown of IKK*ε* significantly increased the expression of LC3-II and ATG-5 (Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"}) after starvation. Western blot analyses also displayed that knockdown of IKK*ε* in H9c2 cells promotes the expression of proteins Bax and cleaved caspase-3 but decreased the expression of protein Bcl-2 (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). Moreover, the number of LC3 puncta stained by immunofluorescent was significantly increased in the siRNA-IKK*ε* group than in the siRNA-control group (Figures [4(c)](#fig4){ref-type="fig"} and [4(d)](#fig4){ref-type="fig"}) in cells under starvation. In the siRNA-IKK*ε* group, the autophagy flux was then blocked by Baf. The LC3-I/II was accumulated, and the apoptotic cells were subsequently reduced when compared with the cells without Baf (Supplementary [2](#supplementary-material-1){ref-type="supplementary-material"}). These results indicate the protective effects of IKK*ε* under starvation injuries in H9c2 cells.

3.5. IKK*ε* Rescue Experiment in H9c2 Cells under Starvation Injury {#sec3.5}
-------------------------------------------------------------------

To further validate the essential role of IKK*ε* in cell autophagy, the rescue experiment with lentivirus over-IKK*ε* and negative control vectors (over-control) was carried out in H9c2 cells. Western blot analyses displayed that the expression of IKK*ε* in siRNA-IKK*ε* and over-IKK*ε* group cells was restored when compared with the siRNA-IKK*ε* and over-control group. In addition, rescue of IKK*ε* decreased autophagy proteins LC3II and ATG-5 expression (Figures [5(a)](#fig5){ref-type="fig"} and [5(b)](#fig5){ref-type="fig"}). Moreover, the number of LC3 puncta which was stained by immunofluorescent was also decreased in siRNA-IKK*ε* and over-IKK*ε* group cells (Figures [5(c)](#fig5){ref-type="fig"} and [5(d)](#fig5){ref-type="fig"}). By rescue, the expression of IKK*ε* in H9c2 cells and proteins Bax and C-caspase-3 was decreased but the expression of protein Bcl-2 was increased after starvation (Figures [5(a)](#fig5){ref-type="fig"} and [5(b)](#fig5){ref-type="fig"}). In brief, these results indicated that IKK*ε* may play an essential role in cell autophagy and thus lead to MI-induced cell death.

3.6. IKK*ε* Mediates Post-MI Cardiomyocyte Autophagy through the Akt/mTOR Pathway {#sec3.6}
---------------------------------------------------------------------------------

To explore the mechanism of IKK*ε* that regulates excessive autophagy in cardiomyocytes, the autophagy-related signaling pathways were test *in vivo* and *in vitro*. The total and phosphorylation levels ERK1/2, MEK1/2, Ikb*α,* and p38 did not change after IKK*ε* was knocked down (Supplementary [3](#supplementary-material-1){ref-type="supplementary-material"}). Deficiency of IKK*ε* in mouse significantly decreased the expression levels of p-Akt and p-mTOR compared with WT mice after MI (Figures [6(a)](#fig6){ref-type="fig"} and [6(b)](#fig6){ref-type="fig"}). Consistently, the expression of p-Akt and p-mTOR also showed a consistent downregulation when IKK*ε* was knocked down by RNAi *in vitro* (Figures [6(e)](#fig6){ref-type="fig"} and [6(f)](#fig6){ref-type="fig"}). To further confirm the correlation between IKK*ε* and Akt/mTOR expressions, rescue experiments *in vitro* were performed. Notably, in rescue cells, the levels of p-Akt and p-mTOR were also restored compared with control group cells (Figures [6(c)](#fig6){ref-type="fig"} and [6(d)](#fig6){ref-type="fig"}). Our results demonstrate that the IKK*ε*-induced excessive autophagy upon MI is largely associated with the activation of AKT-mTOR signalings in the hearts.

4. Discussion and Conclusion {#sec4}
============================

The present work was the first time to demonstrate the critical importance of IKK*ε* in the development of MI, particularly cell autophagy. To investigate the potential function of IKK*ε* in the development of MI and heart failure, a mouse model of MI by occluding the LAD coronary artery was established. Western blotting revealed that IKK*ε* was significantly upregulated in cardiomyocytes and achieved the peak 14 days post-MI (Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"}) which just coincides with the time when cardiomyocytes start autophagy. To elucidate the role of IKK*ε* in MI, a mouse MI model with a global knockout of IKK*ε* was performed. The deficiency of IKK*ε* increased MI-induced excessive autophagy of cardiomyocytes which results in several detrimental effects on the heart such as increased cardiomyocyte loss, infarct size, deteriorating LV functional, aggravated cardiac damage, and finally reduced survival post-MI cells. The lack of IKK*ε* also leads to excessive autophagy *in vitro*. Autophagy was considered to play an important role in the elimination of cardiomyocyte post-MI, and the results mentioned above indicated that IKK*ε* played an important regulatory role in autophagy.

Autophagy was a process of catabolism of cellular components and was necessary for the maintenance of cell homeostasis \[[@B15]\]. Efficient autophagic responses were considered to have beneficial effects post-MI, and many studies indicated that autophagy contributed etiologically to myocardial infarction \[[@B16], [@B17]\]. Matsui et al. reported that Becn1^**+/−**^ mice**---**which were characterized by a partial autophagic defect at the whole-body level---were more resistant to cardiac damage at reperfusion than their WT controls \[[@B7]\]. However, abnormal autophagy was proven to be associated with cardiovascular diseases \[[@B18]\]. The process of autophagy of cardiomyocytes has the bidirectional regulation effect of maintaining cell survival or inducing cell death, that is, an appropriate level of autophagy can maintain the steady state of cardiomyocytes, while excessively activated autophagy can cause cardiomyocyte death and cause serious consequences. Therefore, autophagy plays an essential role in the occurrence of cardiovascular disease \[[@B19]\]. Similarly, the present study showed that loss of IKK*ε* induced excessive autophagy in cardiomyocyte post-MI which resulted in aggravated cardiac damage.

It has been well documented that ischemia leads to a sudden increase of cardiomyocyte apoptosis \[[@B20]\] and caused collective loss of cardiomyocytes throughout the entire pathological process post-MI \[[@B21]\]. Accordingly, the inhibition of cardiomyocyte apoptosis showed potential protection against post-MI cardiac dysfunction and limited infarct size \[[@B22]\]. Mitochondria acted as central regulators of apoptosis when they received stress signals, such as starvation, hypoxia, oxidative stress, and DNA damage from cardiomyocytes \[[@B23]\]. The permeability of mitochondrial membrane was regulated by a family of proteins known as the Bcl-2 family, which includes antiapoptotic (Bcl-2) and proapoptotic (Bax, Bid, Bak, etc.) \[[@B24]\]. Consistently, the present study revealed that lack of IKK*ε* would increase cardiomyocyte death and apoptosis in the ischemic heart by inducing caspase-3 and Bax and inhibiting Bcl-2 activity both *in vivo* (Figures [2(e)](#fig2){ref-type="fig"} and [2(f)](#fig2){ref-type="fig"}) and *in vitro* (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}). These results suggested that IKK*ε* might mediated cardiomyocyte apoptosis via the mitochondrial apoptosis pathway. Moreover, previous evidences have showed the antiapoptosis effect of IKK*ε* in different types of cells. Renner et al. reported that IKK*ε* accumulates in subnuclear promyelocytic leukemia (PML) bodies upon genotoxic stress, where it undergoes SUMOylation, leading to its activation and ultimately resulting in NF-*κ*B-mediated antiapoptotic responses \[[@B25]\]. Additionally, several glioma cell lines and human primary glioma tissues exhibit elevated levels of IKK*ε* and were less sensitive to DNA damage-induced apoptosis \[[@B26]\], whereas suppression of IKK*ε* leads to cells becoming more sensitive, which were also consistent with our experimental findings \[[@B27]\].

The present study suggested that IKK*ε* might play a protective role on cardiomyocyte survival post-MI while its molecular mechanisms remained unclear. The Akt/mTOR pathway was a major signal transduction pathway which is responsible for regulating cell proliferation, survival, autophagy, and apoptosis. This study displayed that IKK*ε*-mediated post-MI cardiomyocyte death was largely dependent on the inhibition of the Akt/mTOR signaling pathways both *in vivo* and *in vitro* ([Figure 6](#fig6){ref-type="fig"}). The mTOR was a master regulator of several crucial cellular processes, including protein synthesis, cellular growth, proliferation, autophagy, lysosomal function, and cell metabolism \[[@B28], [@B29]\]. The mTOR pathway regulated both physiological and pathological processes in the cardiovascular system. Partial or selective inhibition of mTOR conferred cardioprotection in multiple cardiac pathological conditions \[[@B30]\]. As revealed in this study, the deficiency of IKK*ε* significantly inhibited the expression levels of p-Akt and p-mTOR and subsequently leading to cardiomyocyte death and deterioration of cardiac function when compared with control group both *in vivo* and *in vitro*. Eventually, rescuing IKK*ε* by overexpression *in vitro* could partially restore the expression of p-Akt and p-mTOR levels. Similar evidences were also reported that IKK*ε* might promote cell survival by directly phosphorylating Akt \[[@B31], [@B32]\]. One limitation of this research was that the results of MI remodeling *in vivo* were based on a global knockout of IKK*ε* and we could not guarantee that IKK*ε* deficiency of other cell types might have contributed to the observed effects on the heart. In addition, we used rat embryonic cardiac myoblasts (H9c2 cells) instead of cardiomyocytes isolated form the heart of embryonic mice in the in vitro experiments which may account for some differences.

In summary, this study presents the first evidence that IKK*ε* was a critical protective mediator in the process of cardiac remodeling in response to MI. The deficiency of IKK*ε* would cause excessive autophagy of cardiomyocyte and eventually lead to exacerbate infarct size expansion and deteriorate cardiac function post-MI. Therefore, we propose that targeting IKK*ε* is a promising approach for preventing or treating MI.
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![IKK*ε* levels were increased in cardiomyocytes of the mouse postinfarction hearts. (a) Representative images of H&E staining, Masson staining, and immunohistochemical staining of IKK*ε* transverse sections from a sham heart and an infarcted heart at 14 days after MI (*n* = 6 for each group; magnification, 200x). Scale bar represents 100 *μ*m. (b, c) IKK*ε* expression levels of the mouse hearts were detected via western blotting analysis (*n* = 5 per experimental group). ^∗∗∗^*P* \< 0.001. (d) Immunofluorescence staining images labeling IKK*ε* (green) and troponin (red) in the border zones of MI mice at 14 days (*n* = 5 for each group; magnification, 200x). Scale bars represent 100 *μ*m. Each experiment was repeated 3 times.](OMCL2020-7046923.001){#fig1}

![Effects of IKK*ε* deficiency on survival, infarct size, and cardiac function after MI. (a) Representative western blots of IKK*ε* expression in heart tissues from wild-type (WT) littermates and KO mice (*n* = 6 for each group). (b) Kaplan-Meier survival analysis for WT MI and KO MI mice (*n* = 31 for WT MI group, *n* = 30 for WT MI group). (c) Echocardiographic analysis of (d) left ventricular end diastolic diameter (LVEDd), (e) left ventricular end systolic diameter (LVESd), (f) fractional shortening (FS), and (g) ejection fraction (EF) at day 28 after the MI or sham operation (*n* = 8 for each group). NS: not significant; ^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01. (h) Representative images of micro-PET, micro-CT, and micro-PET/CT overlap form WT and KO mice at day 28 after MI or sham operation. (i) Quantitative analysis of infarct size at day 28 post-MI in WT and KO mice (*n* = 6 for each group). ^∗∗^*P* \< 0.01.](OMCL2020-7046923.002){#fig2}

![Loss of IKK*ε* induced excessive autophagy and increased apoptosis in cardiomyocytes after MI. (a, b) LC3II, Beclin-1, and ATG-5 expression levels of the mouse hearts after MI were detected via western blotting analysis (*n* = 5 per experimental group). ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001. (c, d) Representative western blots and quantitative results of IKK*ε*, LC3I/II, ATG-5, C-caspase 3, Bcl-2, and Bax in WT and KO mice at 2 weeks after MI or sham operation (*n* = 5 for each group). ^∗∗^*P* \< 0.01; ^∗∗∗^*P* \< 0.001. (e) Representative electron micrographs showing cardiomyocyte autophagy in the border zone of the WT and KO hearts at 2 weeks after MI (*n* = 5‐6 for each group). Scale bar represents 1 nm. (f) The quantification of autophagy is expressed as a percentage of autophagic vacuole area. ^∗∗^*P* \< 0.01. Each experiment was repeated 3 times.](OMCL2020-7046923.003){#fig3}

![Knockdown of IKK*ε* promotes starvation-induced autophagy in H9c2 cells. (a, b) Representative western blots and quantitative results of IKK*ε*, LC3I/II, ATG-5, C-caspase 3, Bcl-2, and Bax in H9c2 cells (*n* = 4 for each group). ^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01; ^∗∗∗^*P* \< 0.001. (c) Representative immunofluorescent staining of LC3 in H9c2 cells (*n* = 4 for each group; magnification, 600x). Scale bar represents 10 *μ*m. (d) The quantification of autophagy is expressed as the number of LC3 puncta per area (*n* = 4 for each group). ^∗∗^*P* \< 0.01.](OMCL2020-7046923.004){#fig4}

![IKK*ε* is essential for H9c2 cell survival under starvation injury. H9c2 cells were infected with siRNA-control and LV-control, siRNA-IKK*ε* and Over-control, and siRNA-IKK*ε* and Over-IKK*ε* three groups with or without starvation injury, a total of 6 groups. (a, b) Representative western blots and quantitative results of IKK*ε*, LC3I/II, ATG-5, C-caspase 3, Bcl-2, and Bax in H9c2 cells of each 6 groups. ^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01; ^∗∗∗^*P* \< 0.001. (c) Representative immunofluorescent staining of LC3 in H9c2 cells of each 6 groups (*n* = 4 for each group; magnification, 600x). Scale bar represents 10 *μ*m. (d) The quantification of autophagy is expressed as the number of LC3 puncta per area (*n* = 4 for each group). ^∗∗^*P* \< 0.01.](OMCL2020-7046923.005){#fig5}

![IKK*ε* mediates cardiomyocyte autophagy through the Akt/mTOR pathway. (a, b) Representative western blots and quantitative results of phosphorylation and total protein levels of AKT and mTOR in WT and KO mice at 2 weeks after MI or sham operation (*n* = 5 for each group). ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001. (c, d) Representative western blots and quantitative results of phosphorylation and total protein levels of AKT and mTOR in H9c2 cells under starvation injury. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001. (e, f) Representative western blots and quantitative results of phosphorylation and total protein levels of AKT and mTOR in H9c2 cells after the rescue of IKK*ε*.](OMCL2020-7046923.006){#fig6}
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